Page last updated: 2024-08-17

quinoxalines and u-50488

quinoxalines has been researched along with u-50488 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jacocks, HM; McMahon, PN; Werling, LL1
Doan, P; Lutfy, K; Nugyen, M; Weber, E1
Doan, P; Lutfy, K; Nguyen, M; Weber, E1
Jackisch, R; Riegert, C; Rothmaier, AK; Rutz, S1
Autar, R; Bouzanne des Mazery, R; Fröhlich, R; Molenveld, P; Schepmann, D; Soeberdt, M; Sterk, GJ; Storcken, RP; van der Haas, RN; van Oss, B; Wünsch, B1

Other Studies

5 other study(ies) available for quinoxalines and u-50488

ArticleYear
Regulation of [3H]dopamine release from guinea pig striatum by NMDA receptor/channel activators and inhibitors.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 255, Issue:1

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Corpus Striatum; Dopamine; Glycine; Guinea Pigs; Ion Channels; Magnesium; Male; N-Methylaspartate; Piperazines; Pyrrolidines; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid

1990
ACEA-1328, an NMDA receptor antagonist, increases the potency of morphine and U50,488H in the tail flick test in mice.
    Pharmacological research, 1998, Volume: 38, Issue:6

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Drug Synergism; Excitatory Amino Acid Antagonists; Male; Mice; Morphine; Pain Measurement; Quinoxalines; Receptors, N-Methyl-D-Aspartate

1998
Effects of ACEA-1328, a NMDA receptor/glycine site antagonist, on U50,488H-induced antinociception and tolerance.
    European journal of pharmacology, 1999, Nov-12, Volume: 384, Issue:1

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Animals; Dose-Response Relationship, Drug; Drug Tolerance; Excitatory Amino Acid Antagonists; Glycine; Male; Mice; Nociceptors; Pain; Pain Measurement; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, kappa

1999
Presynaptic modulation of 5-HT release in the rat septal region.
    Neuroscience, 2007, May-11, Volume: 146, Issue:2

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adrenergic alpha-Agonists; Analgesics, Non-Narcotic; Animals; Brimonidine Tartrate; Calcium; Dose-Response Relationship, Drug; Electric Stimulation; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; In Vitro Techniques; Male; Neurons; Presynaptic Terminals; Pyridines; Pyrroles; Quinoxalines; Quipazine; Rats; Rats, Wistar; Septum of Brain; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists

2007
Conformationally restricted κ-opioid receptor agonists: Synthesis and pharmacological evaluation of diastereoisomeric and enantiomeric decahydroquinoxalines.
    Bioorganic & medicinal chemistry letters, 2015, Nov-15, Volume: 25, Issue:22

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Crystallography, X-Ray; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Molecular Structure; Piperazines; Protein Binding; Pyrrolidines; Quinoxalines; Receptors, Opioid, kappa; Stereoisomerism

2015